Skip to main content
. 2013 Aug;5(4):400–405. doi: 10.3978/j.issn.2072-1439.2013.07.28

Table 2. Response rate after treatment with gefitinib and retreatment.

Initial treatment
Retreatment
Gefitinib Erlotinib Gefitinib Erlotinib
PR, n [%] 9 [45] 4 [30.8] 0 [0] 1 [7.7]
SD, n [%] 4 [20] 5 [38.4] 9 [45] 5 [38.5]
PD, n [%] 7 [35] 4 [30.8] 11 [55] 7 [53.8]
ORR, n [%] 9 [45] 4 [30.8] 0 [0] 1 [7.7]
DCR, n [%] 13 [65] 9 [69.2] 9 [45] 5 [46.2]